Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...

FOR years, Emma Morris hid from cameras, avoided mirrors and felt like a prisoner in her own body because of her weight. But ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Victoza and Saxenda use another GLP-1 agonist, liraglutide. Tirzepatide — Eli Lilly’s branded versions are sold as Mounjaro for blood sugar and Zepbound for weight loss — works on two hormones.

A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...

Lilly's second-quarter results reported Thursday were still more than fine: $15.5 billion in revenue beat Wall Street ...

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says By Jen Christensen, CNN, CNNWire Wednesday, April 17, 2024 ...

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.